Cargando…

M-opsin protein degradation is inhibited by MG-132 in Rpe65(−/−) retinal explant culture

PURPOSE: The 65 kDa retinal pigment epithelium-specific protein, RPE65, is an essential enzyme for 11-cis-retinal synthesis in the eye. Mutations of the RPE65 gene in humans result in severe vision loss, and Rpe65(−/−) mice show early cone photoreceptor degeneration. We used an explant culture syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Kota, Ozaki, Taku, Ishiguro, Sei-ichi, Nakazawa, Mitsuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380917/
https://www.ncbi.nlm.nih.gov/pubmed/22736942
Descripción
Sumario:PURPOSE: The 65 kDa retinal pigment epithelium-specific protein, RPE65, is an essential enzyme for 11-cis-retinal synthesis in the eye. Mutations of the RPE65 gene in humans result in severe vision loss, and Rpe65(−/−) mice show early cone photoreceptor degeneration. We used an explant culture system to evaluate whether posttranslational downregulation of M-opsin protein in Rpe65(−/−) mice is caused by proteolytic degradation. METHODS: The eyes of three-week-old Rpe65(−/−) mice were incubated in culture medium. Western blot analysis was used to evaluate the level of M-opsin protein, and immunofluorescence was used for protein localization. The transcriptional level of M-opsin was evaluated with real-time reverse-transcriptase-PCR. RESULTS: Degradation of the M-opsin protein in Rpe65(−/−) mouse retina was inhibited by the proteasome inhibitor MG-132 but not by the lysosomal inhibitor pepstatin A and E64d. 9-cis-retinal, used as an analog of 11-cis-retinal, increased M-opsin protein but did not increase M-opsin mRNA. Moreover, 9-cis-retinal did not change the transcriptional levels of photoreceptor specific genes. CONCLUSIONS: Our data suggest that M-opsin protein was degraded through a proteasome pathway and that M-opsin degradation was suppressed with 9-cis-retinal treatment in Rpe65(−/−) mice to some extent.